Bioassay Development

Bioassay Development | Biologics, Proteins, Vaccines | Breaking News

Abzena Introduces Enhanced Bioassay Platform

EpiScreen 2.0 predicts and evaluates potential risks of preclinical immunogenicity in protein, antibody and gene therapy therapeutics.

04.26.24

Bioanalytical Services | Bioassay Development | Breaking News | R&D

Frontage Taps Henry Gao as Chief Financial Officer

Gao has more than 25 years of experience in leading various functions including finance, audit, investment, project management, compliance and board office.

02.01.24

Bioassay Development | Breaking News | Drug Development | Drug Discovery | Industry News

Synthego Unveils CRISPR Discovery Partners to Streamline Drug Research

Partnership network combines the power of automated CRISPR cell line engineering with phenotypic, functional and multi-omic assays to optimize research work.

03.17.23

NIIMBL Unveils 3 New Vaccine Manufacturing Projects

Announces $1.7 million from the Global Health Fund.

03.01.23

Ilya Pharma Acquires Nordic Bioanalysis

Site is located at the previous Astra Zeneca site in Södertälje, south of Stockholm.

04.21.22

Bioassay Development | Breaking News | Industry News

Toxys Opens NY Sales Office and Facility in Maryland

Expansion in the U.S. supports the company’s growth strategy.

03.16.22

Bio News | Bioassay Development | Breaking News | Collaborations & Alliances | Industry News

Promega and Fujifilm Cellular Dynamics Enter Assay Development Partnership

New licensing agreement will deliver luminescent reporter technology into iPSCs.

03.10.22

Analytical Services | Bioassay Development | Biologics, Proteins, Vaccines | Drug Development

Host Cell Impurities, Bioassays, Micro-Flow Imaging

WHO, FDA and the European Pharmacopoeia have established strict regulatory guidelines to guarantee product quality in biologics.

Bioanalytical Services | Bioassay Development | Biologics, Proteins, Vaccines

The Future of Continuous Bioprocessing

The modernization of advanced therapy manufacturing.

Dr. Karoline Hahn, Senior Consultant for Advanced Therapies, KCR 06.02.21

Collaboration Creates Bio Hub in Northern UK

CDMO Fujifilm Diosynth Biotechnologies is part of Northern Bio-Accelerator Partnership.

Contract Pharma Staff 12.16.20

Bioassay Development | Biologics, Proteins, Vaccines | Drug Development | Facilities

Opportunities in Synthetic Biology

Les Tillack, CEO of Luina Bio, discusses how ‘synbio’ is driving growth in the biopharma industry.

Sponsored released by 11.17.20

Bioassay Development | Breaking News | Industry News

GenScript Gets EUA for SARS-CoV-2 Neutralizing Antibody Detection Kit

cPass SARS-CoV-2 Neutralization Antibody kit is the only EUA authorized virus-free testing assay that detects neutralizing antibodies within an hour.

Contract Pharma Staff 11.10.20

Bioanalytical Services | Bioassay Development | Biologics, Proteins, Vaccines | Process Development | Process Validation

eBook: Increase Time to Market with Precision Dispensing Technology

Discover how to make safe, productive, efficient bioprocessing a reality by exploring the benefits of precision dispensing technology.

Sponsored released by Roquette 10.30.20

Reaction Biology and 4HF Biotec Collaborate

Announce new cell-based service offering that combines their technologies.

Contract Pharma Staff 10.21.20

Axxam and Fujifilm Cellular Dynamics Enter Alliance

Partner to deliver integrated hiPSC drug discovery solutions.

Contract Pharma Staff 10.08.20

Bioassay Development | Drug Development | Drug Discovery

Technology Selection for Bioavailability Enhancement

Selection of the proper technology can make the difference between development success or failure. Learn more in this whitepaper from Lonza Pharma & Biotech.